ROIV

ROIV

USD

Roivant Sciences Ltd. Common Shares

$19.870+0.320 (1.637%)

Prix en Temps Réel

Healthcare
Biotechnologie
Royaume-Uni

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$19.550

Haut

$19.890

Bas

$19.315

Volume

9.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

13.6B

Industrie

Biotechnologie

Pays

United Kingdom

Statistiques de Trading

Volume Moyen

7.66M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $8.73Actuel $19.870Haut $20.085

Actualités Connexes

GlobeNewswire

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.

Voir plus
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Analyst Upgrades

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25

Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.

Voir plus
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

Voir plus
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
GlobeNewswire

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to

Voir plus
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025